Anti-tumor immune response in early stage non small cell lung cancer (NSCLC): implications for adjuvant therapy

Autor Butts, Charles A.
Vydáno v Transl Lung Cancer Res (2013)

Adjuvant Therapy in Non-Small Cell Lung Cancer: Current and Future Directions

Autor Sangha, Randeep, Price, Julie, Butts, Charles A.
Vydáno 2010

Uptake and Tolerance of Chemotherapy in Elderly Patients with Small Cell Lung Cancer and Impact on Survival

Autor Fisher, Stacey, Al-Fayea, Turki M., Winget, Marcy, Gao, He, Butts, Charles
Vydáno 2012

Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma

Autor Bigam David, Butts Charles, Dixon Elijah, Sutherland Francis, Dowden Scot, Bathe Oliver F, Walley Barb, Ruether Dean, Ernst Scott
Vydáno 2004-07-01

Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma

Autor Bathe, Oliver F, Dowden, Scot, Sutherland, Francis, Dixon, Elijah, Butts, Charles, Bigam, David, Walley, Barb, Ruether, Dean, Ernst, Scott
Vydáno 2004

A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases

Autor Bathe, Oliver F, Ernst, Scott, Sutherland, Francis R, Dixon, Elijah, Butts, Charles, Bigam, David, Holland, David, Porter, Geoffrey A, Koppel, Jennifer, Dowden, Scot
Vydáno 2009

Rapid atrophy of cardiac left ventricular mass in patients with non‐small cell carcinoma of the lung

Autor Kazemi‐Bajestani, Seyyed Mohammad Reza, Becher, Harald, Butts, Charles, Basappa, Naveen S., Smylie, Michael, Joy, Anil Abraham, Sangha, Randeep, Gallivan, Andrea, Kavsak, Peter, Chu, Quincy, Baracos, Vickie E.
Vydáno v J Cachexia Sarcopenia Muscle (2019)

Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non–Small-Cell Lung Cancer: Updated Survival Analysis of J...

Autor Butts, Charles A., Ding, Keyue, Seymour, Lesley, Twumasi-Ankrah, Philip, Graham, Barbara, Gandara, David, Johnson, David H., Kesler, Kenneth A., Green, Mark, Vincent, Mark, Cormier, Yvon, Goss, Glenwood, Findlay, Brian, Johnston, Michael, Tsao, Ming-Sound, Shepherd, Frances A.
Vydáno 2010

Biomarker analysis of the phase 3 TORCH trial for first line erlotinib versus chemotherapy in advanced non-small cell lung cancer patients

Autor Kim, Lucia, Saieg, Mauro, Di Maio, Massimo, Gallo, Ciro, Butts, Charles, Ciardiello, Fortunato, Feld, Ronald, Cheng, Dengxiao, Gebbia, Vittorio, Burgio, Marco Angelo, Alam, Yasmin, Signoriello, Simona, Rossi, Antonio, Leighl, Natasha, Maione, Paolo, Morabito, Alessandro, Liu, Geoffrey, Tsao, Ming-Sound, Perrone, Francesco, Gridelli, Cesare
Vydáno v Oncotarget (2017)

Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study

Autor Goss, Glenwood D., O'Callaghan, Chris, Lorimer, Ian, Tsao, Ming-Sound, Masters, Gregory A., Jett, James, Edelman, Martin J., Lilenbaum, Rogerio, Choy, Hak, Khuri, Fadlo, Pisters, Katherine, Gandara, David, Kernstine, Kemp, Butts, Charles, Noble, Jonathan, Hensing, Thomas A., Rowland, Kendrith, Schiller, Joan, Ding, Keyue, Shepherd, Frances A.
Vydáno 2013

Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis

Autor Antonia, Scott J, Borghaei, Hossein, Ramalingam, Suresh S, Horn, Leora, De Castro Carpeño, Javier, Pluzanski, Adam, Burgio, Marco A, Garassino, Marina, Chow, Laura Q M, Gettinger, Scott, Crinò, Lucio, Planchard, David, Butts, Charles, Drilon, Alexander, Wojcik-Tomaszewska, Joanna, Otterson, Gregory A, Agrawal, Shruti, Li, Ang, Penrod, John R, Brahmer, Julie
Vydáno v Lancet Oncol (2019)

Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial

Autor Wakelee, Heather A., Dahlberg, Suzanne E., Keller, Steven M., Tester, William J., Gandara, David R., Graziano, Stephen L., Adjei, Alex, Leighl, Natasha B., Aisner, Seena C., Rothman, Jan M., Patel, Jyoti D., Sborov, Mark D., McDermott, Sean R., Perez-Soler, Roman, Traynor, Anne M., Butts, Charles, Evans, Tracey, Shafqat, Atif, Chapman, Andrew E., Kasbari, Samer S., Horn, Leora, Ramalingam, Suresh S., Schiller, Joan
Vydáno v Lancet Oncol (2017)

Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer

Autor Borghaei, Hossein, Gettinger, Scott, Vokes, Everett E., Chow, Laura Q. M., Burgio, Marco Angelo, de Castro Carpeno, Javier, Pluzanski, Adam, Arrieta, Oscar, Frontera, Osvaldo Arén, Chiari, Rita, Butts, Charles, Wójcik-Tomaszewska, Joanna, Coudert, Bruno, Garassino, Marina Chiara, Ready, Neal, Felip, Enriqueta, García, Miriam Alonso, Waterhouse, David, Domine, Manuel, Barlesi, Fabrice, Antonia, Scott, Wohlleber, Markus, Gerber, David E., Czyzewicz, Grzegorz, Spigel, David R., Crino, Lucio, Eberhardt, Wilfried Enst Erich, Li, Ang, Marimuthu, Sathiya, Brahmer, Julie
Vydáno v J Clin Oncol (2021)